Kestra Advisory Services’s Moderna MRNA Stock Holding History
Bought
Maintained
Sold
Other funds holding MRNA
TP
Kestra Advisory Services's MRNA Position: Q3 2026 in Review
Kestra Advisory Services reduced its Moderna (MRNA) stake by 2.5% in Q3 2026, selling an estimated $32.7K and leaving 11,713 shares worth $2.26M. The position accounts for 0.01% of the portfolio, ranked #1369.
Kestra Advisory Services first reported a position in MRNA in Q3 2020 and has held it in 25 quarters since. The position peaked at $10.6M in Q3 2021. 1,048 funds tracked by Wall St. Rank hold MRNA as of Q3 2026.
- Kestra Advisory Services held 11,713 shares of Moderna worth $2.26M as of Q3 2026.
- Kestra Advisory Services sold 303 Moderna shares in Q3 2026, an estimated $32.7K.
- Moderna made up 0.01% of Kestra Advisory Services's portfolio in Q3 2026, its #1369 holding.
- Kestra Advisory Services first reported a position in Moderna in Q3 2020 and has held it in 25 quarters since.
- Kestra Advisory Services's Moderna position peaked at $10.6M in Q3 2021.
- 1,048 funds tracked by Wall St. Rank held Moderna as of Q3 2026.
Based on Kestra Advisory Services's 13F filing for Q3 2026, filed 2 Nov 2026.